Tag | Content |
---|
EnhancerAtlas ID | HS095-19279 |
Organism | Homo sapiens |
Tissue/cell | HMEC |
Coordinate | chr21:45303490-45304780 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOSL1 | MA0477.1 | chr21:45303995-45304006 | GATGAGTCACC | - | 6.32 | FOSL2 | MA0478.1 | chr21:45303996-45304007 | ATGAGTCACCC | - | 6.14 | JUNB | MA0490.1 | chr21:45303996-45304007 | ATGAGTCACCC | - | 6.32 | JUND | MA0491.1 | chr21:45303995-45304006 | GATGAGTCACC | - | 6.62 | TCF7L2 | MA0523.1 | chr21:45304087-45304101 | GCCCTTTGATCTCT | - | 6.25 | TFAP2A | MA0003.3 | chr21:45303585-45303596 | TGCCTCAGGCA | + | 6.02 | ZNF263 | MA0528.1 | chr21:45304145-45304166 | CTTCCCCCTCCTCCTTCCCCC | - | 6.37 | ZNF263 | MA0528.1 | chr21:45304118-45304139 | CCACCCGCTTCCCCCTCCTTC | - | 6.52 | ZNF263 | MA0528.1 | chr21:45304131-45304152 | CCTCCTTCCCCCTCCTTCCCC | - | 7.1 | ZNF263 | MA0528.1 | chr21:45304157-45304178 | CCTTCCCCCTCCTCCTTCTCT | - | 7.44 | ZNF263 | MA0528.1 | chr21:45304144-45304165 | CCTTCCCCCTCCTCCTTCCCC | - | 7.53 | ZNF263 | MA0528.1 | chr21:45304128-45304149 | CCCCCTCCTTCCCCCTCCTTC | - | 8.27 | ZNF263 | MA0528.1 | chr21:45304151-45304172 | CCTCCTCCTTCCCCCTCCTCC | - | 8.48 | ZNF263 | MA0528.1 | chr21:45304138-45304159 | CCCCCTCCTTCCCCCTCCTCC | - | 8.88 | ZNF263 | MA0528.1 | chr21:45304141-45304162 | CCTCCTTCCCCCTCCTCCTTC | - | 9.11 | ZNF263 | MA0528.1 | chr21:45304154-45304175 | CCTCCTTCCCCCTCCTCCTTC | - | 9.11 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_24414 | chr21:45303855-45305193 | Colon_Crypt_2 | SE_28487 | chr21:45301529-45305495 | Fetal_Intestine | SE_31723 | chr21:45303707-45305281 | Gastric | SE_40549 | chr21:45301909-45305917 | K562 | SE_43150 | chr21:45303798-45305196 | Lung |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH21I043882 | chr21 | 45301737 | 45305874 |
|
Enhancer Sequence | TGGAGATGGA GTTTCGCTCT GTTGCCCAGG CTGGAGTACA GTGGTATAAT CTCGGCTCAC 60 TGCAGCCTCT GCCTCTTGGG TTCAAGCGAT TCTCCTGCCT CAGGCACCCA AGTAGCTGAG 120 GTTACAGGTG CCCACTGCCA CACCTGGCTA ATTTTTGTAT TTTTAGTAGA GATGGGGTTT 180 TGCCATGTTG GCCAGGCTGG TCTCAAACTT CTGACCTCAG GCAATCCACC TGCCTTGGCC 240 TCCCAAAGTG CTGGGATTAC AGGTGAGAGC CACTGTGCCT AGCTAATTTT GTATTTTTAG 300 TAGAGAGACG GGGTTTCTCC ATGTTGGTCG GGCTGGTCTT GAACTCCTGA GCTCAAGTAA 360 TCCGCTTGCC TCAGCCTCCC AAAGTGCTGG GATTACAGGT GTGAGCCACC ACGCCTGGCC 420 AGTGTTCTGG TCTGTTTGTG ATGGGTGTAA GAATCTGTCT CTTTAAAGAG GTGCCTCTGG 480 CCAGGTGGTT ACCTCTGTCA CCAGAGATGA GTCACCCAGT CTCAGCTCGC AGGCCTTCCT 540 GGACGTTCCC AGATAGTCCC CAGTGCTGGA GGCCTGTCGA AAGTGTAGCT CCACCACGCC 600 CTTTGATCTC TTCCTCCTCT CCTCTTCCCC ACCCGCTTCC CCCTCCTTCC CCCTCCTTCC 660 CCCTCCTCCT TCCCCCTCCT CCTTCTCTCC TGCTGAGGGC ATTTGGCCTC ATAGATAAGC 720 GGTTTCTAAT GAGCTCACTG GTTTCCGATG GTGGGTGGGG AGTGACTCTG GGCTTTCTGT 780 GCTGCCTCTT CGACCTCGTC CCTGTTTTCT GCTGTGCGGA GCATGGCCCT TTCCTAATCC 840 GAAAGAGCCG CACAGTCCCT TCCAGTGCTG CCTGTGGTCT CGCCCAGCTG GCTGTGCTAT 900 TGCGGGACAT GGGGCCCAGC CTCCTGCTCC TTCAGAGGCC TGGGGTGGGT GAGGCTGGGG 960 TGCCCTGGTG CTGGATGCAG GGGTGCTGTG GTGCTGAATG CTGGGGTGCC CTGGTGCTGG 1020 ACGTTGGGTG CCCAGGCACT GGATGCTGGG GTGGCCTGGT GCTGGATGCT GGGTGGCCTG 1080 GTGCTGGGTG GCCTGATGCT GGGTGCTGGG TGGTCTGGTG CTGGATGCTG GGTGGCCTGG 1140 TGCTGGGTGC TGGGTGGCCT GGTGCTGGGT ACTGGGTGCT CTGGTGGTGG ATGCAGAGGC 1200 AGGGCTATCT GTGGGTCTGC CCTTGGGTGT GGGGCAAGCC AGGTCAGCAT ATTGCAAAGC 1260 ACACGTTGGG CTGCTGCTTG TGTAATTGTC 1290
|